Skip to main content

Advertisement

SpringerLink
Log in

Treatments with sodium selenate or doxycycline offset diabetes-induced perturbations of thioredoxin-1 levels and antioxidant capacity

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Diabetes is associated with increased oxidative stress and impaired antioxidant defenses. Thioredoxin-1 (TRX-1) is a cytosolic thiol antioxidant and redox-active protein which plays a vital role in the maintenance of reduced intracellular redox state. In this study, the authors examined whether 4-week treatments with sodium selenate and doxycycline—a metalloproteinase-2 inhibitor which also has antioxidant-like effects—offset perturbations in oxidative stress and antioxidant protection in rat liver and skeletal muscle in streptozotocin-induced diabetes (SID) model. Experimental diabetes decreased TRX-1 levels in skeletal muscle and liver. On the other hand, SID increased oxidative stress marker protein carbonyl levels and decreased oxygen radical absorbance capacity (ORAC), an indicator of antioxidant capacity, in liver. A 4-week treatment of sodium selenate to diabetic rats decreased blood glucose levels moderately, while doxycycline treatment caused a reduction in weight loss of diabetic rats. Both doxycycline and sodium selenate prevented diabetes-induced decrease of TRX-1 levels in skeletal muscle, whereas only doxyxycline was effectively preventing diabetes-induced decrease of TRX-1 in liver. Furthermore, both treatments prevented diabetes-induced altered levels of protein carbonyls and ORAC in liver, and restored free and total protein thiol levels in both skeletal muscle and liver. In conclusion, the data of this study provides further evidence that sodium selenate and doxycycline treatments may control oxidative stress and improve antioxidant defense in diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Nishinaka Y, Nakamura H, Masutani H, Yodoi J (2001) Redox control of cellular function by thioredoxin; a new therapeutic direction in host defence. Arch Immunol Ther Exp (Warsz) 49:285–292

    CAS  Google Scholar 

  2. Atalay M, Laaksonen DE, Niskanen L, Uusitupa M, Hänninen O, Sen CK (1997) Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stres. Acta Physiol Scand 161:195–201

    Article  PubMed  CAS  Google Scholar 

  3. Atalay M, Laaksonen DE (2002) Diabetes, oxidative stress and physical exercise. J Sport Sci Med 1:1–14

    Google Scholar 

  4. Jones DP (2008) Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295:C849–C868

    Article  PubMed  CAS  Google Scholar 

  5. Cantin AM, Hubbard RC, Crystal RG (1989) Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139:370–372

    PubMed  CAS  Google Scholar 

  6. Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R (2000) Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101:1833–1839

    PubMed  CAS  Google Scholar 

  7. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R (2005) Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112:544–552

    Article  PubMed  CAS  Google Scholar 

  8. Lemaitre V, D’armiento J (2006) Matrix metalloproteinases in development and disease. Birth Defects Res C 78:1–10

    Article  CAS  Google Scholar 

  9. Arnér ES, Holmgren A (2006) The thioredoxin system in cancer. Semin Cancer Biol 16:420–426

    Article  PubMed  Google Scholar 

  10. Berggren M, Gallegos A, Gasdaska J, Powis G (1997) Cellular thioredoxin reductase activity is regulated by selenium. Anticancer Res 17:3377–3380

    PubMed  CAS  Google Scholar 

  11. Berggren MM, Mangin JF, Gasdaka JR, Powis G (1999) Effect of selenium on rat thioredoxin reductase activity: increase by supranutritional selenium and decrease by selenium deficiency. Biochem Pharmacol 57:187–193

    Article  PubMed  CAS  Google Scholar 

  12. Yamawaki H, Berk BC (2005) Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels. Curr Opin Nephrol Hypertens 14:149–153

    Article  PubMed  CAS  Google Scholar 

  13. Kakisaka Y, Nakashima T, Sumida Y, Yoh T, Nakamura H, Yodoi J, Senmaru H (2002) Elevation of serum thioredoxin levels in patients with type 2 diabetes. Hom Metab Res 34:160–164

    Article  CAS  Google Scholar 

  14. Miyamoto S, Kawano H, Hokamaki J, Soejima H, Kojima S, Kudoh T, Nagayoshi Y, Sugiyama S, Sakamoto T, Yoshimura M, Nakamura H, Yodoi J, Ogawa H (2005) Increased plasma levels of thioredoxin in patients with glucose intolerance. Intern Med 44:1127–1132

    Article  PubMed  CAS  Google Scholar 

  15. Hokamaki J, Kawano H, Soejima H, Miyamoto S, Kajiwara I, Kojima S, Sakamoto T, Sugiyama S, Yoshimura M, Nakamura H, Yodoi J, Ogawa H (2005) Plasma thioredoxin levels in patients with unstable angina. Int J Cardiol 99:225–231

    Article  PubMed  Google Scholar 

  16. Ayaz M, Ozdemir S, Ugur M, Vassort G, Turan B (2004) Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys 426:83–90

    Article  PubMed  CAS  Google Scholar 

  17. Can B, Ulusu NN, Kilinç K, Leyla Acan N, Saran Y, Turan B (2005) Selenium treatment protects diabetes-induced biochemical and ultrastructural alterations in liver tissue. Biol Trace Elem Res 105:135–150

    Article  PubMed  CAS  Google Scholar 

  18. Berg EA, Wu JY, Campbell L, Kagey M, Stapleton SR (1995) Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats. Biochimie 77:919–924

    Article  PubMed  CAS  Google Scholar 

  19. Yaras N, Sariahmetoglu M, Bilginoglu A, Aydemir-Koksoy A, Onay-Besikci A, Turan B, Schulz R (2008) Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol 155:1174–1184

    Article  PubMed  CAS  Google Scholar 

  20. Golub LM, Ramamurthy N, McNamara T, Greenwald R, Rifkin B (1991) Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2:297–322

    PubMed  CAS  Google Scholar 

  21. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T (1998) Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12:12–26

    Article  PubMed  CAS  Google Scholar 

  22. Yeh YC, Lai HC, Ting CT, Lee WL, Wang LC, Wang KY, Lai HC, Liu TJ (2007) Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol 74:969–980

    Article  PubMed  CAS  Google Scholar 

  23. Soory M (2008) A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: a literature review. Open Dent J 2:5–12

    Article  PubMed  CAS  Google Scholar 

  24. Lappalainen Z, Lappalainen J, Oksala NKJ, Laaksonen DE, Khanna S, Sen CK, Atalay M (2009) Diabetes impairs exercise training-associated thioredoxin response and glutathione status in rat brain. J Appl Physiol 106:461–467

    Article  PubMed  CAS  Google Scholar 

  25. Prior RL, Hoang H, Gu L, Wu X, Bacchiocca M, Howard L, Hampsch-Woodill M, Huang D, Ou B, Jacob R (2003) Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and food samples. J Agric Food Chem 51:3273–3279

    Article  PubMed  CAS  Google Scholar 

  26. Kinnunen S, Hyyppä S, Lehmuskero A, Oksala N, Mäenpää P, Hänninen O, Atalay M (2005) Oxygen radical absorbance capacity (ORAC) and exercise-induced oxidative stress in trotters. Eur J Appl Physiol 95:1–7

    Article  Google Scholar 

  27. Oksala NK, Paimela H, Alhava E, Atalay M (2007) Heat shock preconditioning induces protein carbonylation and alters antioxidant protection in superficially injured guinea pig gastric mucosa in vitro. Dig Dis Sci 52:1897–1905

    Article  PubMed  CAS  Google Scholar 

  28. Turan B, Desilets M, Acan LN, Hotomaroglu O, Vannier C, Vassort G (1996) Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovasc Res 32:351–361

    Article  PubMed  CAS  Google Scholar 

  29. Jotty K, Ojeda ML, Nogales F, Rubio JM, Murillo ML, Carreras O (2009) Selenium tissue distribution changes after ethanol exposure during gestation and lactation: selenite as a therapy. Food Chem Toxicol 47(10):2484–2489

    Article  PubMed  CAS  Google Scholar 

  30. Gan L, Liu Q, Xu HB, Zhu YS, Yang XL (2002) Effects of selenium overexposure on glutathione peroxidase and thioredoxin reductase gene expressions and activities. Biol Trace Elem Res 89(2):165–175

    Article  PubMed  CAS  Google Scholar 

  31. Cao G, Shukitt-Hale B, Bickford PC, Joseph JA, McEwen J, Prior RL (1999) Hyperoxia-induced changes in antioxidant capacity and the effect of dietary antioxidants. J Appl Physiol 86:1817–1822

    Article  PubMed  CAS  Google Scholar 

  32. Shacter E (2000) Quantification and significance of protein oxidation samples. Drug Metab Rev 32:307–326

    Article  PubMed  CAS  Google Scholar 

  33. Stadtman ER, Levine RL (2000) Protein oxidation. Ann N Y Acad Sci 899:191–208

    Article  PubMed  CAS  Google Scholar 

  34. Telci A, Cakatay U, Salman S, Satman I, Sivas A (2000) Oxidative protein damage in early stage type 1 diabetic patients. Diabetes Res Clin Pract 50:213–223

    Article  PubMed  CAS  Google Scholar 

  35. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J (2000) Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 26:163–176

    PubMed  CAS  Google Scholar 

  36. Li X, Xu Z, Li S, Rozanski GJ (2005) Redox regulation of I to remodeling in diabetic rat heart. Am J Physiol Heart Circ Physiol 288:H1417–H1424

    Article  PubMed  CAS  Google Scholar 

  37. Kiersztan A, Baranska A, Hapka M, Lebiedzinska M, Winiarska K, Dudziak M, Bryla J (2009) Differential action of methyselenocysteine in control and alloxan-diabetic rabbits. Chem Biol Interact 27:161–171

    Article  Google Scholar 

  38. Hawkes WC, Alkan Z (2010) Regulation of redox signaling by selenoproteins. Biol Trace Elem Res 134:235–251

    Article  PubMed  CAS  Google Scholar 

  39. Ulusu NN, Turan B (2005) Beneficial effects of selenium on some enzymes of diabetic rat heart. Biol Trace Elem Res 103:207–216

    Article  PubMed  CAS  Google Scholar 

  40. Tuncay E, Seymen AA, Tanriverdi E, Yaras N, Tandogan B, Ulusu NN, Turan B (2007) Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction. Mol Cell Biochem 304:255–263

    Article  PubMed  CAS  Google Scholar 

  41. Ayaz M, Ozdemir S, Yaras N, Vassort G, Turan B (2005) Selenium-induced alterations in ionic currents of rat cardiomyocytes. Biochem Biophys Res Commun 327:163–173; Erratum in: Biochem Biophys Res Commun 329:418

    Google Scholar 

  42. Selenius M, Fernandes AP, Brodin O, Björnstedt M, Rundlöf AK (2008) Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system. Biochem Pharmacol 75:2092–2099

    Article  PubMed  CAS  Google Scholar 

  43. Ramamurthy NS, Vernillo AT, Greenwald RA, Lee HM, Sorsa T, Golub LM, Rifkin BR (1993) Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone Miner Res 8:1247–1253

    Article  PubMed  CAS  Google Scholar 

  44. Ryan ME, Ramamurthy NS, Golub LM (1998) Tetracyclines inhibit protein glycation in experimental diabetes. Adv Dent Res 12:152–158

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study has been supported by grants from the Scientific and Technological Research Council of Turkey (TUBITAK)-SBAG-107S427 and TUBITAK-SBAG-107S304, and the European Cooperation in Science and Technology (COST) action BM0602 to BT, from the Finnish Ministry of Education and COST actions B35 and BM0602 to MA. AB is supported by the ERASMUS program.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Institute of Biomedicine, Physiology, University of Eastern Finland, Kuopio, Finland

    Mustafa Atalay & Tarja Kokkola

  2. Department of Biophysics, Faculty of Medicine, Ankara University, Ankara, Turkey

    Ayca Bilginoglu & Belma Turan

  3. Division of Vascular Surgery, Department of Surgery, Tampere University Hospital, Tampere, Finland

    Niku Oksala

Authors
  1. Mustafa Atalay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayca Bilginoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tarja Kokkola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Niku Oksala
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Belma Turan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Belma Turan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atalay, M., Bilginoglu, A., Kokkola, T. et al. Treatments with sodium selenate or doxycycline offset diabetes-induced perturbations of thioredoxin-1 levels and antioxidant capacity. Mol Cell Biochem 351, 125–131 (2011). https://doi.org/10.1007/s11010-011-0719-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-011-0719-3

Keywords

Search

Navigation